Fintel reports that on January 10, 2025, Morgan Stanley upgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from Equal ...

Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...

Humanities & Social Sciences Communications is a fully open-access, online journal publishing peer-reviewed research from across—and between—all areas of the humanities, behavioral and social ...